Search results for "Heart failure"


 
Results 211 - 220 of about 463 for "Heart failure".
Sort by: Relevance | Newest | Oldest

Prescription NSAIDs associated with heart failure risk, study finds

A 19% increased risk for hospital admission for heart failure was found to be associated with any use of NSAIDs in the preceding 14 days versus past use of any NSAIDs. Diclofenac, ibuprofen, indomethacin, ketorolac, naproxen, nimesulide, piroxicam, etoricoxib, and rofecoxib were associated with increased risk for hospital admission.
https://immattersacp.org/weekly/archives/2016/10/04/1.htm
4 Oct 2016

Early beta-blocker use may reduce 30-day mortality in patients with acute MI

Patients receiving early beta-blockers had a 30-day mortality rate of 2.3%, compared with 8.6% in those who did not, the study found.
https://immattersacp.org/weekly/archives/2016/09/27/4.htm
27 Sep 2016

Ischemic heart disease linked to worse prognosis in heart failure patients with type 2 diabetes

Type 2 diabetes was associated with greater risk for all-cause mortality in patients with ischemic and nonischemic heart failure, previous revascularization was associated with better survival, and most patients with type 2 diabetes and nonischemic heart failure had at least 1 treatable comorbid condition associated with heart failure risk.
https://immattersacp.org/weekly/archives/2016/09/20/4.htm
20 Sep 2016

Sacubitril-valsartan appears cost-effective in certain heart failure patients

Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016

CPAP didn't reduce cardiac events in patients with obstructive sleep apnea and pre-existing CVD

Prescribing continuous positive airway pressure with the sole purpose of reducing future cardiovascular events in asymptomatic patients with obstructive sleep apnea and established cardiovascular disease cannot be recommended, an editorial stated.
https://immattersacp.org/weekly/archives/2016/08/30/1.htm
30 Aug 2016

CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care

A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016

MKSAP Quiz: 3-month history of gradually progressive abdominal distention

A 68-year-old woman is evaluated for a 3-month history of gradually progressive abdominal distention. Her medical history is notable for a 20-year history of obesity, type 2 diabetes mellitus, hyperlipidemia, and hypertension. She also has had a 10-year history of elevation of serum aminotransferase levels, which was attributed to nonalcoholic fatty liver disease. She does not consume alcohol. Her medications are metformin, lisinopril, low-dose aspirin, and simvastatin. Following physical and abdominal exams, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/08/09/3.htm
9 Aug 2016

AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products

The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016

Keys to taking a neurological history

The most powerful tool in neurology is the history and physical exam, including the requirement that patients walk in the presence of neurologists, in order to better understand symptoms.
https://immattersacp.org/archives/2016/07/neurology.htm
1 Jul 2016

NAFLD treatment starts with weight loss, then other modes

Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016

Result Page: Prev   17   18   19   20   21   22   23   24   25   26   Next